Development of new anti-cancer treatments: fundamental research and innovative bioclinical and therapeutic research (study of chromosomes, transcriptome, intracellular signalling pathways, apoptosis, etc.).
CRCNA is a research center integrating 18 teams and 3 research axes: immunology & immunotherapy, oncogenesis and cancer & ionization radiations. One of CRCNA missions is to perform research in Nuclear Oncology & Radiobiology and endothelial Targeting. The aim is to realize preclinical and clinical research in molecular imaging and vectorized radiotherapy.